Skip to main content
Fig. 4 | Health Research Policy and Systems

Fig. 4

From: Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process

Fig. 4

Survey results show that HRQoL evidence from a validated instrument is seen as essential but fit with guidance is the greatest barrier to wider adoption in France. Data from a survey of 14 ex-HTA directors (5 ex-HAS in France, 5 ex-NICE in the United Kingdom and 4 ex-IQWiG in Germany) between the 21 and 31st of January. See Additional file 1: Methods for the detailed list of questions asked. A Percent of experts who stated that HRQoL data was “essential” or “very important” for each of the therapeutic areas listed; B percent of experts who stated that the following principles determined the acceptability of a HRQoL instrument; C percent of experts who stated the following as the most important barriers to further uptake of HRQoL data in their respective countries

Back to article page

Health Research Policy and Systems

ISSN: 1478-4505

Contact us